A detailed history of Invesco Ltd. transactions in Harvard Bioscience Inc stock. As of the latest transaction made, Invesco Ltd. holds 16,123 shares of HBIO stock, worth $34,503. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,123
Previous 99,047 83.72%
Holding current value
$34,503
Previous $282,000 84.75%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$2.64 - $3.54 $218,919 - $293,550
-82,924 Reduced 83.72%
16,123 $43,000
Q2 2024

Aug 13, 2024

BUY
$2.77 - $4.63 $115,558 - $193,154
41,718 Added 72.77%
99,047 $282,000
Q1 2024

May 14, 2024

BUY
$4.02 - $5.39 $45,554 - $61,079
11,332 Added 24.64%
57,329 $243,000
Q4 2023

Feb 12, 2024

BUY
$4.0 - $5.49 $32,636 - $44,792
8,159 Added 21.56%
45,997 $246,000
Q3 2023

Nov 13, 2023

BUY
$4.0 - $5.82 $71,456 - $103,968
17,864 Added 89.44%
37,838 $162,000
Q2 2023

Aug 11, 2023

BUY
$4.19 - $6.16 $83,691 - $123,039
19,974 New
19,974 $109,000
Q2 2022

Aug 15, 2022

SELL
$3.28 - $6.42 $47,251 - $92,486
-14,406 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$5.16 - $7.14 $202,235 - $279,838
-39,193 Reduced 73.12%
14,406 $89,000
Q4 2021

Feb 14, 2022

SELL
$6.37 - $8.18 $89,670 - $115,149
-14,077 Reduced 20.8%
53,599 $378,000
Q3 2021

Nov 15, 2021

BUY
$6.98 - $8.47 $54,457 - $66,082
7,802 Added 13.03%
67,676 $473,000
Q2 2021

Aug 17, 2021

SELL
$5.44 - $8.4 $56,744 - $87,620
-10,431 Reduced 14.84%
59,874 $499,000
Q1 2021

May 17, 2021

SELL
$3.91 - $6.99 $38,943 - $69,620
-9,960 Reduced 12.41%
70,305 $383,000
Q4 2020

Feb 16, 2021

BUY
$3.0 - $4.5 $47,172 - $70,758
15,724 Added 24.36%
80,265 $344,000
Q3 2020

Nov 16, 2020

SELL
$2.75 - $4.2 $4,196 - $6,409
-1,526 Reduced 2.31%
64,541 $194,000
Q2 2020

Aug 14, 2020

BUY
$2.12 - $3.14 $19,224 - $28,473
9,068 Added 15.91%
66,067 $205,000
Q1 2020

May 15, 2020

BUY
$1.42 - $3.29 $80,938 - $187,526
56,999 New
56,999 $126,000

Others Institutions Holding HBIO

About HARVARD BIOSCIENCE INC


  • Ticker HBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 41,636,500
  • Market Cap $89.1M
  • Description
  • Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...
More about HBIO
Track This Portfolio

Track Invesco Ltd. Portfolio

Follow Invesco Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.